Year: 2017

The U.S. Food and Drug Administration (FDA) recently sent a warning letter to the company that makes Mylan’s EpiPen emergency allergy treatment products. In the letter, the FDA accuses the company of failing to fully investigate “serious and life-threatening” EpiPen failures or to take “appropriate corrective actions.” The FDA delivered…